Vitamin D derivatives with selective modulatory activity on the vitamin D receptor (VDR) [24,25,26] have been developed for the treatment of VDR-related diseases, including bone and calcium diseases, malignancies, immune and inflammatory diseases, and metabolic disease. This evidence concerns the gene VDR and Other metabolic disease.